AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2016

Jan 4, 2016

5229_dirs_2016-01-04_3dea2707-532f-4ac7-ad64-09e7106d24fc.html

Director's Dealing

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7436K

AstraZeneca PLC

04 January 2016

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 3 January 2016, Pascal Soriot, a Director of the Company, notified us that, on 31 December 2015, he ceased to be beneficially interested in 250,100 AstraZeneca PLC Ordinary Shares of $0.25 each as a result of a gift of those shares to family members for nil consideration.

A C N Kemp

Company Secretary

4 January 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUSUORNRAARAR

AI assistant

AstraZeneca PLC — Director's Dealing 2016

5229_dirs_2016-01-04_3dea2707-532f-4ac7-ad64-09e7106d24fc.html

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

More from AstraZeneca PLC

AstraZeneca PLC Director's Dealing 2016